Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Eyebright Medical Technology (Beijing) Co EV-to-EBIT?
Eyebright Medical Technology (Beijing) CoSHSE:688050 75 EV-to-EBIT is 29.16 as of Sep. 22, 2026, which is 53% below its 10-year median of 61.91. GuruFocus rates SHSE:688050 with a GF Score™ of 75/100 and a GF Value™ of ¥111.54 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 482 Medical Devices & Instruments companies, Eyebright Medical Technology (Beijing) Co ranks worse than 70.33% on this metric.
SHSE:688050's EV-to-EBIT is ranked worse than 70.33% of 482
companies
in the Medical Devices & Instruments industry
Industry Median: 18.035
vs SHSE:688050: 29.16
Eyebright Medical Technology (Beijing) Co (SHSE:688050) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Eyebright Medical Technology (Beijing) Co's Enterprise Value for the quarter that ended in Jun. 2026 was ¥7,778 Mil.
Eyebright Medical Technology (Beijing) Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥285 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co EV-to-EBIT Related Terms
Eyebright Medical Technology (Beijing) Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co EV-to-EBIT Chart
Eyebright Medical Technology (Beijing) Co Annual Data
SHSE:688050 vs ISRG, BDX, RMD: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eyebright Medical Technology (Beijing) Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eyebright Medical Technology (Beijing) Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Eyebright Medical Technology (Beijing) Co's EV-to-EBIT falls into.
Eyebright Medical Technology (Beijing) Co's current Enterprise Value is ¥8,317 Mil.
Eyebright Medical Technology (Beijing) Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥285 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co (SHSE:688050) has a EV-to-EBIT of 29.16 as of Sep. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. This is 53% below median its historical median of 61.91. Over the past decade, Eyebright Medical Technology (Beijing) Co's EV-to-EBIT has ranged from 25.27 to 250.09. According to the industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #339 out of 482 companies in the Medical Devices & Instruments industry, placing it in the top 70.3%.
Is Eyebright Medical Technology (Beijing) Co's EV-to-EBIT too high?
Eyebright Medical Technology (Beijing) Co's current EV-to-EBIT of 29.16 is 53% below median its 10-year median of 61.91. Over the past 10 years, this metric has ranged from a low of 25.27 to a high of 250.09. The Medical Devices & Instruments industry median EV-to-EBIT is 18.04. Eyebright Medical Technology (Beijing) Co's value of 29.16 is 61.7% above this industry median. Based on the distribution chart, Eyebright Medical Technology (Beijing) Co ranks #339 out of 482 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eyebright Medical Technology (Beijing) Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Eyebright Medical Technology (Beijing) Co's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #339 out of 482 companies for EV-to-EBIT. This places Eyebright Medical Technology (Beijing) Co in the lower half of its industry. The industry median EV-to-EBIT is 18.04. Eyebright Medical Technology (Beijing) Co's value of 29.16 is 61.7% above this benchmark. Historically, Eyebright Medical Technology (Beijing) Co's own EV-to-EBIT has ranged from 25.27 to 250.09 over the past decade. While the company's 10-year median is 61.91 vs. the industry median of 18.04, Eyebright Medical Technology (Beijing) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.04, based on 482 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eyebright Medical Technology (Beijing) Co's current EV-to-EBIT of 29.16 is 61.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eyebright Medical Technology (Beijing) Co's current EV-to-EBIT is 29.16, which is 53% below median its own 10-year median of 61.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eyebright Medical Technology (Beijing) Co stock overvalued right now?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co (SHSE:688050) is currently considered Possible Value Trap. The stock's GF Value™ is ¥111.54, compared to a current price of ¥38.95 — trading 65.1% below its estimated fair value. The current EV-to-EBIT is 29.16, which is 53% below median its 10-year median of 61.91 and 61.7% above the Medical Devices & Instruments industry median of 18.04. Eyebright Medical Technology (Beijing) Co's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Eyebright Medical Technology (Beijing) Co (SHSE:688050), the current EV-to-EBIT is 29.16 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eyebright Medical Technology (Beijing) Co (SHSE:688050) Overvalued in 2026?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co stock appears to be undervalued.
The current stock price of ¥38.95 is trading 65.1% below its estimated GF Value™ of ¥111.54.
GuruFocus considers Eyebright Medical Technology (Beijing) Co to be Possible Value Trap.
Key valuation signals for SHSE:688050:
EV-to-EBIT: 29.16 (53% below median its 10-year median of 61.91)
GF Value™: ¥111.54 vs. price of ¥38.95 (65.1% below fair value)
Industry Position: 61.7% above the Medical Devices & Instruments median (#339 of 482)
No single metric tells the full story. See the SHSE:688050 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
75GF Score
Get the complete analysis for SHSE:688050
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688050 has been successfully added to your 
